Global Human Leukocyte Antigen (HLA) Typing Market Growth 2026-2032

October 2026 | 129 pages | ID: HDB4B8FBCFB2EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Human Leukocyte Antigen (HLA) Typing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Human leukocyte antigen (HLA) typing determines if patients and donors are compatible for cord blood or bone marrow transplants. Human leukocyte antigens (HLA) are proteins found in our bodies. The human immune system uses these markers to determine which cells belong in your body and which cells are foreign.

United States market for Human Leukocyte Antigen (HLA) Typing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Human Leukocyte Antigen (HLA) Typing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Human Leukocyte Antigen (HLA) Typing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Human Leukocyte Antigen (HLA) Typing players cover Thermo Fisher Scientific, QIAGEN, Illumina, CareDx, Immucor, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Human Leukocyte Antigen (HLA) Typing Industry Forecast” looks at past sales and reviews total world Human Leukocyte Antigen (HLA) Typing sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Leukocyte Antigen (HLA) Typing sales for 2026 through 2032. With Human Leukocyte Antigen (HLA) Typing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Leukocyte Antigen (HLA) Typing industry.

This Insight Report provides a comprehensive analysis of the global Human Leukocyte Antigen (HLA) Typing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Leukocyte Antigen (HLA) Typing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Leukocyte Antigen (HLA) Typing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Leukocyte Antigen (HLA) Typing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Leukocyte Antigen (HLA) Typing.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Leukocyte Antigen (HLA) Typing market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

  • Reagent
  • Instrument

Segmentation by Application:

  • Hospital
  • Specialty Clinic
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific
  • QIAGEN
  • Illumina
  • CareDx
  • Immucor
  • Bio-Rad Laboratories, Inc
  • F. Hoffman-La Roche Ltd
  • Hologic, Inc
  • Luminex Corporation
  • Biofortuna
  • Bruker
  • Abbott
  • Takara Bio Inc
  • Omixon Inc
  • Siemens
  • EKF Diagnostics
  • BD
  • Fujirebio
  • TBG Diagnostics Limited

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Human Leukocyte Antigen (HLA) Typing market?
  • What factors are driving Human Leukocyte Antigen (HLA) Typing market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Human Leukocyte Antigen (HLA) Typing market opportunities vary by end market size?
  • How does Human Leukocyte Antigen (HLA) Typing break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Leukocyte Antigen (HLA) Typing Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Human Leukocyte Antigen (HLA) Typing by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Human Leukocyte Antigen (HLA) Typing by Country/Region, 2021, 2025 & 2032
2.2 Human Leukocyte Antigen (HLA) Typing Segment by Type
  2.2.1 Reagent
  2.2.2 Instrument
  2.2.3 Human Leukocyte Antigen (HLA) Typing Sales by Type
    2.2.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Human Leukocyte Antigen (HLA) Typing Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Human Leukocyte Antigen (HLA) Typing Sale Price by Type (2021-2026)
2.3 Human Leukocyte Antigen (HLA) Typing Segment by Application
  2.3.1 Hospital
  2.3.2 Specialty Clinic
  2.3.3 Other
  2.3.4 Human Leukocyte Antigen (HLA) Typing Sales by Application
    2.3.4.1 Global Human Leukocyte Antigen (HLA) Typing Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Human Leukocyte Antigen (HLA) Typing Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Human Leukocyte Antigen (HLA) Typing Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Human Leukocyte Antigen (HLA) Typing Breakdown Data by Company
  3.1.1 Global Human Leukocyte Antigen (HLA) Typing Annual Sales by Company (2021-2026)
  3.1.2 Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Company (2021-2026)
3.2 Global Human Leukocyte Antigen (HLA) Typing Annual Revenue by Company (2021-2026)
  3.2.1 Global Human Leukocyte Antigen (HLA) Typing Revenue by Company (2021-2026)
  3.2.2 Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Company (2021-2026)
3.3 Global Human Leukocyte Antigen (HLA) Typing Sale Price by Company
3.4 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Product Location Distribution
  3.4.2 Players Human Leukocyte Antigen (HLA) Typing Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HUMAN LEUKOCYTE ANTIGEN (HLA) TYPING BY GEOGRAPHIC REGION

4.1 World Historic Human Leukocyte Antigen (HLA) Typing Market Size by Geographic Region (2021-2026)
  4.1.1 Global Human Leukocyte Antigen (HLA) Typing Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Human Leukocyte Antigen (HLA) Typing Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Leukocyte Antigen (HLA) Typing Market Size by Country/Region (2021-2026)
  4.2.1 Global Human Leukocyte Antigen (HLA) Typing Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Human Leukocyte Antigen (HLA) Typing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Leukocyte Antigen (HLA) Typing Sales Growth
4.4 APAC Human Leukocyte Antigen (HLA) Typing Sales Growth
4.5 Europe Human Leukocyte Antigen (HLA) Typing Sales Growth
4.6 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Growth

5 AMERICAS

5.1 Americas Human Leukocyte Antigen (HLA) Typing Sales by Country
  5.1.1 Americas Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026)
  5.1.2 Americas Human Leukocyte Antigen (HLA) Typing Revenue by Country (2021-2026)
5.2 Americas Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026)
5.3 Americas Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Leukocyte Antigen (HLA) Typing Sales by Region
  6.1.1 APAC Human Leukocyte Antigen (HLA) Typing Sales by Region (2021-2026)
  6.1.2 APAC Human Leukocyte Antigen (HLA) Typing Revenue by Region (2021-2026)
6.2 APAC Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026)
6.3 APAC Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Human Leukocyte Antigen (HLA) Typing by Country
  7.1.1 Europe Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026)
  7.1.2 Europe Human Leukocyte Antigen (HLA) Typing Revenue by Country (2021-2026)
7.2 Europe Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026)
7.3 Europe Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing by Country
  8.1.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026)
8.3 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Leukocyte Antigen (HLA) Typing
10.3 Manufacturing Process Analysis of Human Leukocyte Antigen (HLA) Typing
10.4 Industry Chain Structure of Human Leukocyte Antigen (HLA) Typing

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Human Leukocyte Antigen (HLA) Typing Distributors
11.3 Human Leukocyte Antigen (HLA) Typing Customer

12 WORLD FORECAST REVIEW FOR HUMAN LEUKOCYTE ANTIGEN (HLA) TYPING BY GEOGRAPHIC REGION

12.1 Global Human Leukocyte Antigen (HLA) Typing Market Size Forecast by Region
  12.1.1 Global Human Leukocyte Antigen (HLA) Typing Forecast by Region (2027-2032)
  12.1.2 Global Human Leukocyte Antigen (HLA) Typing Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Leukocyte Antigen (HLA) Typing Forecast by Type (2027-2032)
12.7 Global Human Leukocyte Antigen (HLA) Typing Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Thermo Fisher Scientific
  13.1.1 Thermo Fisher Scientific Company Information
  13.1.2 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Thermo Fisher Scientific Main Business Overview
  13.1.5 Thermo Fisher Scientific Latest Developments
13.2 QIAGEN
  13.2.1 QIAGEN Company Information
  13.2.2 QIAGEN Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.2.3 QIAGEN Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 QIAGEN Main Business Overview
  13.2.5 QIAGEN Latest Developments
13.3 Illumina
  13.3.1 Illumina Company Information
  13.3.2 Illumina Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.3.3 Illumina Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Illumina Main Business Overview
  13.3.5 Illumina Latest Developments
13.4 CareDx
  13.4.1 CareDx Company Information
  13.4.2 CareDx Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.4.3 CareDx Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 CareDx Main Business Overview
  13.4.5 CareDx Latest Developments
13.5 Immucor
  13.5.1 Immucor Company Information
  13.5.2 Immucor Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.5.3 Immucor Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Immucor Main Business Overview
  13.5.5 Immucor Latest Developments
13.6 Bio-Rad Laboratories, Inc
  13.6.1 Bio-Rad Laboratories, Inc Company Information
  13.6.2 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.6.3 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Bio-Rad Laboratories, Inc Main Business Overview
  13.6.5 Bio-Rad Laboratories, Inc Latest Developments
13.7 F. Hoffman-La Roche Ltd
  13.7.1 F. Hoffman-La Roche Ltd Company Information
  13.7.2 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.7.3 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 F. Hoffman-La Roche Ltd Main Business Overview
  13.7.5 F. Hoffman-La Roche Ltd Latest Developments
13.8 Hologic, Inc
  13.8.1 Hologic, Inc Company Information
  13.8.2 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.8.3 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Hologic, Inc Main Business Overview
  13.8.5 Hologic, Inc Latest Developments
13.9 Luminex Corporation
  13.9.1 Luminex Corporation Company Information
  13.9.2 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.9.3 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Luminex Corporation Main Business Overview
  13.9.5 Luminex Corporation Latest Developments
13.10 Biofortuna
  13.10.1 Biofortuna Company Information
  13.10.2 Biofortuna Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.10.3 Biofortuna Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Biofortuna Main Business Overview
  13.10.5 Biofortuna Latest Developments
13.11 Bruker
  13.11.1 Bruker Company Information
  13.11.2 Bruker Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.11.3 Bruker Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Bruker Main Business Overview
  13.11.5 Bruker Latest Developments
13.12 Abbott
  13.12.1 Abbott Company Information
  13.12.2 Abbott Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.12.3 Abbott Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Abbott Main Business Overview
  13.12.5 Abbott Latest Developments
13.13 Takara Bio Inc
  13.13.1 Takara Bio Inc Company Information
  13.13.2 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.13.3 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Takara Bio Inc Main Business Overview
  13.13.5 Takara Bio Inc Latest Developments
13.14 Omixon Inc
  13.14.1 Omixon Inc Company Information
  13.14.2 Omixon Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.14.3 Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Omixon Inc Main Business Overview
  13.14.5 Omixon Inc Latest Developments
13.15 Siemens
  13.15.1 Siemens Company Information
  13.15.2 Siemens Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.15.3 Siemens Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Siemens Main Business Overview
  13.15.5 Siemens Latest Developments
13.16 EKF Diagnostics
  13.16.1 EKF Diagnostics Company Information
  13.16.2 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.16.3 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 EKF Diagnostics Main Business Overview
  13.16.5 EKF Diagnostics Latest Developments
13.17 BD
  13.17.1 BD Company Information
  13.17.2 BD Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.17.3 BD Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 BD Main Business Overview
  13.17.5 BD Latest Developments
13.18 Fujirebio
  13.18.1 Fujirebio Company Information
  13.18.2 Fujirebio Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.18.3 Fujirebio Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Fujirebio Main Business Overview
  13.18.5 Fujirebio Latest Developments
13.19 TBG Diagnostics Limited
  13.19.1 TBG Diagnostics Limited Company Information
  13.19.2 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
  13.19.3 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 TBG Diagnostics Limited Main Business Overview
  13.19.5 TBG Diagnostics Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Human Leukocyte Antigen (HLA) Typing Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Leukocyte Antigen (HLA) Typing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Reagent
Table 4. Major Players of Instrument
Table 5. Global Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026) & (K Units)
Table 6. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
Table 7. Global Human Leukocyte Antigen (HLA) Typing Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Type (2021-2026)
Table 9. Global Human Leukocyte Antigen (HLA) Typing Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Human Leukocyte Antigen (HLA) Typing Sale by Application (2021-2026) & (K Units)
Table 11. Global Human Leukocyte Antigen (HLA) Typing Sale Market Share by Application (2021-2026)
Table 12. Global Human Leukocyte Antigen (HLA) Typing Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Application (2021-2026)
Table 14. Global Human Leukocyte Antigen (HLA) Typing Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Human Leukocyte Antigen (HLA) Typing Sales by Company (2021-2026) & (K Units)
Table 16. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Company (2021-2026)
Table 17. Global Human Leukocyte Antigen (HLA) Typing Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Company (2021-2026)
Table 19. Global Human Leukocyte Antigen (HLA) Typing Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Human Leukocyte Antigen (HLA) Typing Producing Area Distribution and Sales Area
Table 21. Players Human Leukocyte Antigen (HLA) Typing Products Offered
Table 22. Human Leukocyte Antigen (HLA) Typing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Leukocyte Antigen (HLA) Typing Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Leukocyte Antigen (HLA) Typing Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Leukocyte Antigen (HLA) Typing Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Leukocyte Antigen (HLA) Typing Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026) & (K Units)
Table 34. Americas Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country (2021-2026)
Table 35. Americas Human Leukocyte Antigen (HLA) Typing Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026) & (K Units)
Table 37. Americas Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026) & (K Units)
Table 38. APAC Human Leukocyte Antigen (HLA) Typing Sales by Region (2021-2026) & (K Units)
Table 39. APAC Human Leukocyte Antigen (HLA) Typing Sales Market Share by Region (2021-2026)
Table 40. APAC Human Leukocyte Antigen (HLA) Typing Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026) & (K Units)
Table 42. APAC Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026) & (K Units)
Table 43. Europe Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026) & (K Units)
Table 44. Europe Human Leukocyte Antigen (HLA) Typing Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026) & (K Units)
Table 46. Europe Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Leukocyte Antigen (HLA) Typing
Table 52. Key Market Challenges & Risks of Human Leukocyte Antigen (HLA) Typing
Table 53. Key Industry Trends of Human Leukocyte Antigen (HLA) Typing
Table 54. Human Leukocyte Antigen (HLA) Typing Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Leukocyte Antigen (HLA) Typing Distributors List
Table 57. Human Leukocyte Antigen (HLA) Typing Customer List
Table 58. Global Human Leukocyte Antigen (HLA) Typing Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Human Leukocyte Antigen (HLA) Typing Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Leukocyte Antigen (HLA) Typing Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Human Leukocyte Antigen (HLA) Typing Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Leukocyte Antigen (HLA) Typing Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Human Leukocyte Antigen (HLA) Typing Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Leukocyte Antigen (HLA) Typing Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Human Leukocyte Antigen (HLA) Typing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Leukocyte Antigen (HLA) Typing Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Human Leukocyte Antigen (HLA) Typing Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Leukocyte Antigen (HLA) Typing Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Human Leukocyte Antigen (HLA) Typing Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Scientific Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 74. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. QIAGEN Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 78. QIAGEN Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 79. QIAGEN Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. QIAGEN Main Business
Table 81. QIAGEN Latest Developments
Table 82. Illumina Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 83. Illumina Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 84. Illumina Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Illumina Main Business
Table 86. Illumina Latest Developments
Table 87. CareDx Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 88. CareDx Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 89. CareDx Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. CareDx Main Business
Table 91. CareDx Latest Developments
Table 92. Immucor Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 93. Immucor Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 94. Immucor Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Immucor Main Business
Table 96. Immucor Latest Developments
Table 97. Bio-Rad Laboratories, Inc Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 98. Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 99. Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Bio-Rad Laboratories, Inc Main Business
Table 101. Bio-Rad Laboratories, Inc Latest Developments
Table 102. F. Hoffman-La Roche Ltd Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 103. F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 104. F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. F. Hoffman-La Roche Ltd Main Business
Table 106. F. Hoffman-La Roche Ltd Latest Developments
Table 107. Hologic, Inc Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 108. Hologic, Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 109. Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Hologic, Inc Main Business
Table 111. Hologic, Inc Latest Developments
Table 112. Luminex Corporation Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 113. Luminex Corporation Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 114. Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Luminex Corporation Main Business
Table 116. Luminex Corporation Latest Developments
Table 117. Biofortuna Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 118. Biofortuna Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 119. Biofortuna Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Biofortuna Main Business
Table 121. Biofortuna Latest Developments
Table 122. Bruker Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 123. Bruker Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 124. Bruker Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Bruker Main Business
Table 126. Bruker Latest Developments
Table 127. Abbott Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 128. Abbott Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 129. Abbott Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Abbott Main Business
Table 131. Abbott Latest Developments
Table 132. Takara Bio Inc Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 133. Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 134. Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Takara Bio Inc Main Business
Table 136. Takara Bio Inc Latest Developments
Table 137. Omixon Inc Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 138. Omixon Inc Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 139. Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Omixon Inc Main Business
Table 141. Omixon Inc Latest Developments
Table 142. Siemens Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 143. Siemens Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 144. Siemens Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Siemens Main Business
Table 146. Siemens Latest Developments
Table 147. EKF Diagnostics Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 148. EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 149. EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. EKF Diagnostics Main Business
Table 151. EKF Diagnostics Latest Developments
Table 152. BD Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 153. BD Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 154. BD Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. BD Main Business
Table 156. BD Latest Developments
Table 157. Fujirebio Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 158. Fujirebio Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 159. Fujirebio Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Fujirebio Main Business
Table 161. Fujirebio Latest Developments
Table 162. TBG Diagnostics Limited Basic Information, Human Leukocyte Antigen (HLA) Typing Manufacturing Base, Sales Area and Its Competitors
Table 163. TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Product Portfolios and Specifications
Table 164. TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. TBG Diagnostics Limited Main Business
Table 166. TBG Diagnostics Limited Latest Developments

LIST OF FIGURES

Figure 1. Picture of Human Leukocyte Antigen (HLA) Typing
Figure 2. Human Leukocyte Antigen (HLA) Typing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Leukocyte Antigen (HLA) Typing Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Leukocyte Antigen (HLA) Typing Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Leukocyte Antigen (HLA) Typing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country/Region (2025)
Figure 10. Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Reagent
Figure 12. Product Picture of Instrument
Figure 13. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type in 2026
Figure 14. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Type (2021-2026)
Figure 15. Human Leukocyte Antigen (HLA) Typing Consumed in Hospital
Figure 16. Global Human Leukocyte Antigen (HLA) Typing Market: Hospital (2021-2026) & (K Units)
Figure 17. Human Leukocyte Antigen (HLA) Typing Consumed in Specialty Clinic
Figure 18. Global Human Leukocyte Antigen (HLA) Typing Market: Specialty Clinic (2021-2026) & (K Units)
Figure 19. Human Leukocyte Antigen (HLA) Typing Consumed in Other
Figure 20. Global Human Leukocyte Antigen (HLA) Typing Market: Other (2021-2026) & (K Units)
Figure 21. Global Human Leukocyte Antigen (HLA) Typing Sale Market Share by Application (2025)
Figure 22. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Application in 2026
Figure 23. Human Leukocyte Antigen (HLA) Typing Sales by Company in 2026 (K Units)
Figure 24. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Company in 2026
Figure 25. Human Leukocyte Antigen (HLA) Typing Revenue by Company in 2026 ($ millions)
Figure 26. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Company in 2026
Figure 27. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Human Leukocyte Antigen (HLA) Typing Sales 2021-2026 (K Units)
Figure 30. Americas Human Leukocyte Antigen (HLA) Typing Revenue 2021-2026 ($ millions)
Figure 31. APAC Human Leukocyte Antigen (HLA) Typing Sales 2021-2026 (K Units)
Figure 32. APAC Human Leukocyte Antigen (HLA) Typing Revenue 2021-2026 ($ millions)
Figure 33. Europe Human Leukocyte Antigen (HLA) Typing Sales 2021-2026 (K Units)
Figure 34. Europe Human Leukocyte Antigen (HLA) Typing Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Revenue 2021-2026 ($ millions)
Figure 37. Americas Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country in 2026
Figure 38. Americas Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Country (2021-2026)
Figure 39. Americas Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
Figure 40. Americas Human Leukocyte Antigen (HLA) Typing Sales Market Share by Application (2021-2026)
Figure 41. United States Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Human Leukocyte Antigen (HLA) Typing Sales Market Share by Region in 2026
Figure 46. APAC Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Region (2021-2026)
Figure 47. APAC Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
Figure 48. APAC Human Leukocyte Antigen (HLA) Typing Sales Market Share by Application (2021-2026)
Figure 49. China Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 53. India Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country in 2026
Figure 57. Europe Human Leukocyte Antigen (HLA) Typing Revenue Market Share by Country (2021-2026)
Figure 58. Europe Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
Figure 59. Europe Human Leukocyte Antigen (HLA) Typing Sales Market Share by Application (2021-2026)
Figure 60. Germany Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 61. France Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Market Share by Application (2021-2026)
Figure 68. Egypt Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Human Leukocyte Antigen (HLA) Typing Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Human Leukocyte Antigen (HLA) Typing in 2026
Figure 74. Manufacturing Process Analysis of Human Leukocyte Antigen (HLA) Typing
Figure 75. Industry Chain Structure of Human Leukocyte Antigen (HLA) Typing
Figure 76. Channels of Distribution
Figure 77. Global Human Leukocyte Antigen (HLA) Typing Sales Market Forecast by Region (2027-2032)
Figure 78. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Human Leukocyte Antigen (HLA) Typing Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Human Leukocyte Antigen (HLA) Typing Revenue Market Share Forecast by Application (2027-2032)